"How do you live without a stomach?": A multiple case study examination of total gastrectomy for palliation or prophylaxis

被引:10
作者
Garland, Sheila N. [1 ,2 ]
Lounsberry, Joshua [2 ]
Pelletier, Guy [1 ,2 ,3 ]
Bathe, Oliver F. [3 ,4 ]
机构
[1] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
[2] Alberta Hlth Serv, Dept Psychosocial Resources, Tom Baker Canc Ctr, Calgary, AB, Canada
[3] Univ Calgary, Dept Oncol, Calgary, AB T2N 1N4, Canada
[4] Univ Calgary, Dept Surg, Calgary, AB T2N 1N4, Canada
关键词
Cancer; QL; Stomach neoplasms; TG; Medical decision making; Quality of life; Total gastrectomy; DIFFUSE GASTRIC-CANCER; QUALITY-OF-LIFE; E-CADHERIN GENE; DECISION-MAKING; BRCA2; MUTATION; STATISTICS; EXPERIENCE; MANAGEMENT; MASTECTOMY; OPTIONS;
D O I
10.1017/S1478951511000253
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: The number of diagnosed cases of stomach cancer in Western countries is relatively small compared to prevalence rates in Eastern populations. This disparity creates a general lack of information and understanding of the experience of patients treated for this disease in NorthAmerica. Surgical removal of the stomach, also called total gastrectomy (TG), is presently the only curative treatment available to patients with stomach cancer. Considering the impact such a procedure may have, very little is known about what factors influence an individual's postsurgical quality of life (QL). Method: This article reviews current literature and examines three unique case studies. Semi-structured interviews were analyzed using content analysis, a qualitative analytic approach for reporting combined subject responses. Results: Participants included one 37-year-old man with multiple polyps in his stomach and a family history of stomach cancer, one 18 year-old man with a confirmed CDH1 mutation and a family history of stomach cancer, and one 33-year-old man with confirmed metastatic gastric adenocarcinoma. Subjective patient experience was categorized into: (1) making the decision, (2) treatment impact, and (3) life after TG. Prior to surgery, all patients carefully evaluated their perceived risk compared to the treatment consequences and indicated that a certain event triggered their decision. The largest treatment impacts were learning to eat again and adjusting to the physical changes. Each patient endorsed that their experience made them appreciate and make the most of life. Significance of results: This currently represents the only study to investigate the lived experience of TG for prophylaxis or palliation in individuals with and without genetic risk for stomach cancer. Understanding this process will allow all members of the cancer care team, and the patients themselves, to better understand the factors involved in decision making and postoperative adjustment. Fruitful avenues for future research are discussed.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 31 条
[1]  
[Anonymous], 1980, Content analysis
[2]   Health-related quality of life and survival in the 2 years after surgery for gastric cancer [J].
Avery, K. ;
Hughes, R. ;
McNair, A. ;
Alderson, D. ;
Barham, P. ;
Blazeby, J. .
EJSO, 2010, 36 (02) :148-154
[3]   Hereditary diffuse gastric cancer: Diagnosis and management [J].
Blair, V ;
Martin, I ;
Shaw, D ;
Winship, I ;
Kerr, D ;
Arnold, J ;
Harawira, P ;
McLeod, M ;
Parry, S ;
Charlton, A ;
Findlay, M ;
Cox, B ;
Humar, B ;
More, H ;
Guilford, P .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) :262-275
[4]   Prophylactic surgery in the complex decision-making management of BRCA mutation carriers [J].
Briasoulis, Evangelos ;
Ziogas, Dimosthenis ;
Fatouros, Michael .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (06) :1788-1790
[5]   Hereditary diffuse gastric cancer - Implications of genetic testing for screening and prophylactic surgery [J].
Cisco, Robin M. ;
Ford, James M. ;
Norton, Jeffrey A. .
CANCER, 2008, 113 (07) :1850-1856
[6]   Quality of life in patients with oesophageal and gastric cancer: An overview [J].
Conroy, Thierry ;
Marchal, Frederic ;
Blazeby, Jane M. .
ONCOLOGY, 2006, 70 (06) :391-402
[7]   Gastric adenocarcinoma - Review and considerations for future directions [J].
Dicken, BJ ;
Bigam, DL ;
Cass, C ;
Mackey, JR ;
Joy, AA ;
Hamilton, SM .
ANNALS OF SURGERY, 2005, 241 (01) :27-39
[8]   Prospective Evaluation of the Reliability, Validity, and Minimally Important Difference of the Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) Quality-of-Life Instrument [J].
Garland, Sheila N. ;
Pelletier, Guy ;
Lawe, Andrew ;
Biagioni, Bradly J. ;
Easaw, Jay ;
Eliasziw, Michael ;
Cella, David ;
Bathe, Oliver F. .
CANCER, 2011, 117 (06) :1302-1312
[9]  
Green KL, 1997, CAN MED ASSOC J, V157, pS17
[10]   Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients [J].
Hebbard, P. C. ;
MacMillan, A. ;
Huntsman, D. ;
Kaurah, P. ;
Carneiro, F. ;
Wen, X. ;
Kwan, A. ;
Boone, D. ;
Bursey, F. ;
Green, J. ;
Fernandez, B. ;
Fontaine, D. ;
Wirtzfeld, D. A. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1890-1895